-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Anavex Life Sciences Corp. quarterly Deferred Tax Assets, Gross history and growth rate for Q3 2023.
- Anavex Life Sciences Corp. Deferred Tax Assets, Gross for the quarter ending September 30, 2023 was $7.2M.
Deferred Tax Assets, Gross, Quarterly (USD)